Answers are grounded in this paper and cite their sources.
SUMMARY Evidence‐based platelet transfusion therapy has been facilitated by a recent number of clinical trials addressing issues of optimal trigger, dose, product efficacy and adverse events. Valid results depend upon carefully planning the study including: developing a well‐defined research question and hypothesis; selecting the most appropriate study design; identifying all aspects of the optimal intervention to be studied; selecting a clinically relevant outcome measure; determining the sample size requirements; and planning the analysis a priori. Safety issues also need to be considered during the planning stage and often includes the implementation of a data safety monitoring board. Websites that provide useful information and checklists to facilitate researchers when designing clinical studies include: CONSORT ( http://www.consort‐statement.org/index.html ) and the ICH (International Conference on Harmonization) of Technical Requirements for Registration of Pharmaceutical for Human use ( http://www.ich.org ).
No takes yet. Share an insight, caveat, or question.
Heddle et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: